# Early Detection of Breast Cancer

> **NCT06043661** · — · UNKNOWN · sponsor: **Datar Cancer Genetics Inc** · enrollment: 700 (estimated)

## Conditions studied

- Breast Neoplasms

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06043661
- **Lead sponsor:** Datar Cancer Genetics Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-09
- **Primary completion:** 2023-12
- **Final completion:** 2025-12
- **Target enrollment:** 700 (ESTIMATED)
- **Last updated:** 2023-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06043661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06043661, "Early Detection of Breast Cancer". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT06043661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*